In addition, inherited BRCA1 or BRCA2 germline mutations may dramatically increase the risk of secondary tumors in “normal” tissue encompassing the tumor, which is also partly irradiated during radiotherapy. This evidence concerns the gene BRCA1 and neoplasm.